Ditchcarbon
  • Contact
  1. Organizations
  2. Dexcom
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Medical Device Manufacturing
US
updated 24 days ago

Dexcom

Company website

Dexcom, Inc., a leading player in the diabetes care industry, is headquartered in the United States. Founded in 1999, the company has pioneered continuous glucose monitoring (CGM) technology, significantly enhancing diabetes management for patients worldwide. With a strong presence in North America, Europe, and Asia, Dexcom focuses on developing innovative solutions that empower individuals to take control of their health. The company's flagship products, including the Dexcom G6 and G7 CGM systems, offer real-time glucose monitoring with exceptional accuracy and ease of use. These devices are distinguished by their ability to provide users with actionable insights, helping to prevent hypoglycaemic events and improve overall glycaemic control. Dexcom's commitment to innovation has solidified its position as a market leader, recognised for its contributions to diabetes management and patient care.

DitchCarbon Score

How does Dexcom's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

40

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Dexcom's score of 40 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

63%

Let us know if this data was useful to you

Dexcom's reported carbon emissions

In 2023, Dexcom, Inc. reported total carbon emissions of approximately 6652000 kg CO2e for Scope 1, 25291000 kg CO2e for Scope 2, and a significant 479576000 kg CO2e for Scope 3 emissions. This reflects a total of about 31943000 kg CO2e for Scope 1 and 2 combined. The Scope 3 emissions are primarily driven by purchased goods and services, which account for about 325942000 kg CO2e. Comparatively, in 2022, Dexcom's emissions were approximately 4768000 kg CO2e for Scope 1, 13610000 kg CO2e for Scope 2, and minimal Scope 3 emissions reported at about 1749000 kg CO2e. This indicates a notable increase in emissions across all scopes in 2023, particularly in Scope 3. Dexcom has made commitments towards climate action, although their near-term target status has been marked as "Committed" as of June 2023. However, previous commitments have expired, indicating a need for renewed focus on long-term sustainability goals. The company has not set a net-zero target as of now. All emissions data is sourced directly from Dexcom, Inc., with no cascaded data from parent or related organizations. The company operates within the healthcare equipment and supplies sector and is headquartered in the United States.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2020202120222023
Scope 1
2,044,000
0,000,000
0,000,000
0,000,000
Scope 2
9,371,000
00,000,000
00,000,000
00,000,000
Scope 3
1,257,000
0,000,000
0,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Dexcom's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Dexcom is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Dexcom is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Chembio Diagnostics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 29 days ago

MicroTech Medical (Hangzhou) Co., Ltd.

CN
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 16 days ago

Stryker

US
•
Health and social work services (85)
Updated about 5 hours ago

Shanghai Kehua Bio-Engineering Co.,Ltd

CN
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Cigna Healthcare

US
•
Health and social work services (85)
Updated 6 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251008.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy